Product NDC: | 0093-0041 |
Proprietary Name: | ClomiPHENE Citrate |
Non Proprietary Name: | ClomiPHENE citrate |
Active Ingredient(s): | 50 mg/1 & nbsp; ClomiPHENE citrate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0093-0041 |
Labeler Name: | Teva Pharmaceuticals USA Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018361 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 19921101 |
Package NDC: | 0093-0041-65 |
Package Description: | 3 BLISTER PACK in 1 CARTON (0093-0041-65) > 10 TABLET in 1 BLISTER PACK |
NDC Code | 0093-0041-65 |
Proprietary Name | ClomiPHENE Citrate |
Package Description | 3 BLISTER PACK in 1 CARTON (0093-0041-65) > 10 TABLET in 1 BLISTER PACK |
Product NDC | 0093-0041 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ClomiPHENE citrate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19921101 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Teva Pharmaceuticals USA Inc |
Substance Name | CLOMIPHENE CITRATE |
Strength Number | 50 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |